September 05, 2012

FaegreBD Insights

Preclinical Innovation: The Essential Bridge from Basic Research to Therapeutic Development


NIH Director of Preclinical Innovation Division to Discuss Research to Therapies Bridge

FaegreBD Consulting is pleased to invite you to join us for lunch and a featured presentation by
Chris Austin, MD, the director of The Division of Preclinical Innovation, National Center for Advancing Translational Sciences at the National Institutes of Health.

Dr. Austin's appearance is part of the FaegreBD Insights series where national leaders address key topics of interest to our client sectors. We proudly announce the launch of the series with this initial installment.

Dr. Austin will address: "Preclinical Innovation: The Essential Bridge from Basic Research to Therapeutic Development."

As the future installments of the series approach, we will continue to feature a variety of professional experts addressing important topics in their fields. We are excited to host the FaegreBD Insights series as we know it will bring value to clients and friends of the firm alike.



The Metropolitan Club
Anderson Room
1700 H Street NW   
Washington, DC 20036

Services and Industries


11:30 a.m. – 12:00 p.m. EDT | Registration and Mingle

12:00 p.m. - 1:30 p.m. EDT | Presentation

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.